Reading room

Peptide medicines & new families.

Explore how defined peptide medicines work in specific clinical settings, from melanocortin signaling and amylin to GLP-2, local gut receptors and bone biology. Keep molecular identity, formulation, indications and measured outcomes together.

Reset filters

Guides in this topic

1–12 of 19 guides

Page 1 of 2
three-dimensional trabecular-bone teaching specimen placed between two different evidence binders Abaloparatide and Teriparatide, in the Abaloparatide vs Teriparatide research file.Peptide Fundamentals

Abaloparatide vs Teriparatide: Bone Peptide Evidence

Abaloparatide and teriparatide are related to PTH-family biology and have product-specific osteoporosis evidence.

Updated 2026-10-29 ↗
Two physically thick identity dossiers Afamelanotide and Melanotan II, with distinct product-record and early-study evidence sleeves, in the Afamelanotide vs Melanotan II research file.Peptide Fundamentals

Afamelanotide vs Melanotan II: Why the Difference Matters

Afamelanotide’s regulated implant record concerns pain-free light exposure in adults with erythropoietic protoporphyria.

Updated 2026-10-29 ↗
coagulation-research specimen plate and a artery-lumen teaching specimen, in a Thrombin archive folder, in the Bivalirudin research file.Peptide Fundamentals

Bivalirudin: A Peptide Targeting Thrombin During PCI

Bivalirudin is a peptide anticoagulant that directly inhibits thrombin. Its percutaneous-coronary-intervention evidence concerns a clinical strategy with specified comparators, accompanying medicines and event definitions.

Updated 2026-10-29 ↗
kidney teaching specimen, a small water-analysis glass vessel and a arterial-pressure research instrument photograph, in the Desmopressin vs Vasopressin research file.Peptide Fundamentals

Desmopressin vs Vasopressin: Water Balance Is Not Blood Pressure

Desmopressin and vasopressin are related peptides, but their clinical questions are not interchangeable.

Updated 2026-10-29 ↗
kidney teaching specimen beside a detailed skin sensory-ending model, archived as two linked objects, in the Difelikefalin research file.Peptide Fundamentals

Difelikefalin: A Peptide for a Specific CKD-Associated Itch Question

Difelikefalin addresses a specific itch question in adults receiving hemodialysis, rather than chronic kidney disease as a whole.

Updated 2026-10-29 ↗
Separated cell-membrane teaching sections and a fusion-step research envelope in an enfuvirtide archive file.Peptide Fundamentals

Enfuvirtide: A Peptide That Targets HIV Fusion

Enfuvirtide is a peptide antiretroviral that targets a stage of HIV-1 entry: fusion of viral and cellular membranes.

Updated 2026-10-29 ↗
Single platelet teaching specimen in the center of two identity files Eptifibatide and Tirofiban, with one IIb/IIIa index tab, in the Eptifibatide vs Tirofiban research file.Peptide Fundamentals

Eptifibatide vs Tirofiban: Same Platelet Target, Different Molecules

Eptifibatide and tirofiban act at platelet glycoprotein IIb/IIIa, yet their structures are different: eptifibatide is a cyclic peptide and tirofiban is a nonpeptide antagonist.

Updated 2026-10-29 ↗
Archival scientific-name genealogy file with a Exendin-4 source identity card and a Exenatide medicine-identity research card, with a GLP-1 index tab, in the Exenatide and Exendin-4 research file.Peptide Fundamentals

Exenatide and Exendin-4: A Different GLP-1 Peptide Design

Exenatide is related to exendin-4 and acts at the GLP-1 receptor, but the product’s formulation remains central to its evidence.

Updated 2026-10-29 ↗
Two distinct clinical context files: a glucose-rescue laboratory sample photograph and a metabolic receptor-research assay photograph, in the Glucagon research file.Peptide Fundamentals

Glucagon: Why Rescue Medicine and Metabolic Coagonism Differ

Glucagon rescue medicines and glucagon-containing metabolic coagonists use a related biological pathway to answer different clinical questions.

Updated 2026-10-29 ↗
Detailed vessel-wall teaching model with an interstitial-fluid research compartment, partly revealed from a Bradykinin receptor dossier, in the Icatibant research file.Peptide Fundamentals

Icatibant: Why Bradykinin-Mediated Angioedema Is a Different Target

Icatibant targets the bradykinin B2 receptor. That mechanism is why its hereditary-angioedema evidence should be read separately from familiar allergy narratives centered on histamine.

Updated 2026-10-29 ↗
Lispro and glargine sequence-design cards beside a formulation vessel and chronometer in an insulin research file.Peptide Fundamentals

Insulin Analogues: How Sequence and Formulation Change the Profile

Insulin analogues show why small sequence changes and formulation choices can alter a peptide medicine’s time profile.

Updated 2026-10-29 ↗
intestinal epithelial teaching model with two clipped identity records Linaclotide and Plecanatide and one GC-C tab, in the Linaclotide vs Plecanatide research file.Peptide Fundamentals

Linaclotide vs Plecanatide: Peptides Acting in the Gut

Linaclotide and plecanatide are peptide GC-C agonists with product-specific gastrointestinal indications.

Updated 2026-10-29 ↗

Explore the related peptide dossiers

Peptide Medicines & Emerging Research Families | PeptideTwo